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Purpose: To demonstrate the utility of high resolution 20 MHz ophthalmic ultrasound in serial 
follow-up of optic nerve head melanocytoma patients.
Methods: This study is a retrospective review of 30 patients with melanocytoma of the optic 
nerve head studied with echography. All patients were evaluated with standard ophthalmic 
A-scan and B-scan ultrasonography and 10 (33%) underwent high-resolution ultrasound.
Results: Sixty-two percent (62%) of patients had dome-shaped lesions on ultrasound, 
  twenty-eight percent (28%) presented with mild elevations. The maximum elevation of any lesion 
was 2.6 mm. The vast majority (89%) of lesions had medium or high internal   reflectivity and 89% 
demonstrated avascularity. Mean follow-up for all patients was nearly 7 years. High-resolution 
ultrasound enabled enhanced accuracy for detection of lesion dimensions and documentation 
of growth and possible malignant transformation.
Conclusions: In this study, we demonstrate a new and important role for the use of ultrasound 
in this disease as a complementary tool in identifying and following patients with high-risk 
growth characteristics. These tumor characteristics can be accurately detected with 10 MHz 
ultrasound in conjunction with standardized A-scan and better differentiated with the 20 MHz 
technology. Use of these modalities can aid in distinguishing the melanocytomas that grow from 
choroidal melanomas and can prevent unnecessary treatments.
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Introduction
Melanocytoma is a benign intraocular lesion composed of a uniform array of deeply 
pigmented, plump, polyhedral nevus cells.1 It occurs most commonly on or adjacent 
to the optic disc, although it may appear in the choroid, ciliary body, iris, conjunctiva, 
or sclera. Studies have indicated that a significant percentage of optic nerve head mel-
anocytomas grow if followed long-term, and that there are 3 risk factors for growth: 
increased tumor thickness, presence of intrinsic vascularization, and dome shape. His-
torically, echography has not been considered helpful in establishing the diagnosis of 
melanocytoma.2 In this report we present the utility of echography, with special focus 
on high-resolution imaging, for 30 patients with optic disc melanocytomas.
Materials and methods
Thirty-five patients with melanocytoma of the optic nerve head were identified in a review 
of medical charts at a single center institutional practice. Clinical variables collected for the 
study included presenting symptoms, ophthalmic and ultrasound characteristics,   treatment, 
and follow-up. All patients whose lesions   demonstrated interval growth   underwent Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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  high-resolution (20 MHz) imaging (Cinescan S, Quantel 
Medical,   Clermont-Ferrand, France). All had undergone stan-
dard ophthalmic A-scan and contact B-scan   ultrasonography 
(Cinescan S, Quantel Medical, Clermont-Ferrand, France) and 
ten underwent high-resolution ultrasound. The mean follow-up 
for all patients was nearly 7 years. Exclusion criteria included 
follow-up shorter than 3 months in five patients.
Results
Twenty-three of the patients were female (77%), and seven 
(23%) were male. Nineteen (63%) of the lesions were in the 
left eye, and eleven (37%) were in the right eye. The mean age 
of the patients at diagnosis was 50 years. Nineteen patients 
(63%) had their lesions detected on routine ophthalmic 
examination, and five patients (17%) reported a decrease in 
visual acuity. The remainder underwent eye examinations for 
varying reasons such as trauma or post-cataract surgery. The 
majority of the patients (83%) had a corrected visual acuity 
of 20/30 or better on exam at diagnosis. Mean follow-up for 
all patients was 80 months (6.7 years).
Echographic features of the lesions are demonstrated 
in Table 1. All of the patients whose lesions demonstrated 
interval growth underwent high-resolution (20 MHz)   imaging, 
which confirmed stable lesion dimensions and lack of extraoc-
ular extension. Of the 30 melanocytoma patients in this study, 
one patient’s lesion underwent malignant   transformation 
to melanoma, two underwent laser ablation of an associ-
ated choroidal neovascularization (CNV), two were given 
high-dose oral steroids and low-dose aspirin for 2 weeks for 
central retinal vascular obstruction (CRVO), one was given 
bevacizumab (Genentech, Inc., South San   Francisco, CA) for 
vitreous hemorrhage, and another was treated with aspirin for 
branch retinal artery occlusion (BRAO).
The following two cases exemplify the utility of high-
resolution ultrasound in enabling enhanced accuracy for the 
detection of lesion dimensions and documentation of growth 
and possible transformation associated with these lesions.
Case #1
A 36 year-old female with no past medical history was 
referred for evaluation of a mass of the optic nerve head. The 
patient’s visual acuity was 20/50+ in the right eye and 20/20 
in the left eye. The pupils were reactive and the visual field 
was constricted to confrontation inferonasally in the right 
eye. Dilated funduscopic examination revealed a pigmented 
lesion of the optic nerve head (Figure 1A). Standardized 
10 MHz ophthalmic B-scan ultrasound   demonstrated a 
  dome-shaped lesion at the optic nerve head and standardized 
A-scan showed high internal reflectivity and a maximum 
elevation of 2.1 mm (Figure 1B). Six months later, the 
patient presented for follow-up examination. The visual 
acuity was stable but the right pupil demonstrated a new 
Table 1 Clinical and echographic features of 30 patients with 
melanocytoma
Feature Number of patients (%)
Laterality n = 30
  OD 11 (37%)
  OS 19 (63%)
Gender n = 30
 M 7 (23%)
  F 23 (77%)
Age at presentation (years) n = 30
  Mean 50
  Median 47
  Range 17–79
Presenting symptom n = 30
  Routine Exam 19 (63%)
  Decreased visual acuity 5 (17%)
  Other (floaters, metamorphopsia, etc) 6 (20%)
Shape n = 29
  Dome 18 (62%)
  Mild elevation 8 (28%)
  Irregular 3 (10%)
Maximum elevation (mm) n = 30
  Mean 1.3*
  Median 1.3
  Range 1–2.6
Maximum basal diameter (mm) n = 29
  Mean 2.1
  Median 2.25
  Range 1–4.5
Internal reflectivity n = 26
  High 19 (73%)
  Medium – High 3 (12%)
  Medium 1 (4%)
  Low 3 (12%)
Vascularity n = 19
  Vascular 2 (11%)
  Avascular 17 (89%)
Growth over time n = 29
  Increase in size 5 (17%)
  Decrease in size 2 (7%)
  No Change 22 (76%)
  Mean magnitude of change (mm) ± 0.8
Malignant transformation 1 (3%)
Treatment n = 30
  Observation 24 (80%)
  Enucleation 1 (3%)
   Other (aspirin, steroids,  
laser ablation, etc)
5 (17%)
Follow-up (months) n = 30
  Mean 80
  Median 49
  Range 3–513
Note: *For statistical calculations, lesions that could best be quantified as ‘less than 
1 mm’ were counted as 0.5 mm.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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afferent pupillary defect. Given this finding, standardized and 
high-resolution ultrasound examinations were performed. 
Standardized ophthalmic ultrasound demonstrated a nodular 
lesion with medium reflectivity. High resolution ultrasound 
identified an identical maximum elevation of 2.1 mm from 
the previous ultrasound, a smooth, dome-shaped contour, and 
no extraocular extension (Figure 1C). On A-scan, internal 
reflectivity was high. These characteristics were reassuring 
for lack of malignant transformation.
Case #2
A 45 year-old female with no significant past ocular history 
aside from an earlier thermal corneal injury was referred by 
an outside ophthalmologist for evaluation of an unknown 
fundus lesion. The patient’s visual acuity was 20/20 in both 
eyes. Funduscopic examination showed an irregular lesion 
overlying and surrounding the inferior aspect of the optic 
disc in the right eye (Figure 2A), and standard ultrasound 
demonstrated the dimensions of the low-reflective lesion to 
be 1.3 × 5 × 5 mm (apical × basal dimensions) with mild 
vascularity (Figure 2C). Although the lesion was too small 
for differentiation, internal characteristics were suggestive 
of melanoma. However, on clinical examination, a diagnosis 
of melanocytoma was established. The lesion was followed 
with serial ultrasound and remained stable in size until 
three years later, when examination revealed that the lesion 
had rapidly grown in size (Figure 2B). In conjunction with 
standardized A-scan, high-resolution 20 MHz B-scans were 
taken, definitively demonstrating the increased vasculature 
and growth of the lesion to 3.4 × 7 × 6.5 mm (Figure 2D). 
These features were suggestive of malignant transformation, 
confirming the new diagnosis of uveal melanoma. The patient 
subsequently underwent enucleation of her right eye. His-
topathologic analysis demonstrated a malignant epithelioid 
melanoma arising from an area of polyhedral cells consistent 
with malignant transformation of a melanocytoma.
Discussion
The differential diagnosis of pigmented tumors of the optic 
nerve includes malignant melanoma, nevi, melanocytoma, 
hyperplasia of the peripapillary retinal pigment epithelium, 
and hamartomas of the retinal pigment epithelium and sen-
sory retina.2,18 Distinguishing these lesions from malignant 
melanomas is important, given the potentially aggressive 
nature of untreated choroidal melanomas and the unfortu-
nate cases in which patients with melanocytomas undergo 
enucleation unnecessarily.
Historically, clinicians have focused primarily on the 
fundoscopic features of melanocytomas in order to distin-
guish them from melanomas. Anecdotal evidence at large 
clinical centers suggests that reliance on this method of 
diagnosis has been successful the vast majority of the time. 
Nonetheless, there have been several reported diagnostic 
dilemmas, including presumed melanocytomas later found 
to be melanomas,3,4 presumed melanomas identified on 
histopathology as melanocytomas,5,6 and lesions in which 
histopathology demonstrated foci of both melanoma and 
melanocytoma cells.7–9 Most likely there have been addi-
tional unpublished cases in which these two diagnoses were 
confused. Guidelines for distinguishing the two entities must 
be clarified to avoid inappropriate management of patients 
with ambiguous-appearing lesions.
Authors of previously reported large series either have 
noted that ultrasound was not useful in making the diagnosis 
of melanocytoma or have not mentioned the use of ultrasound 
at all.1,2,10 The echographic features of the 30   melanocytomas 
described in this patient series (Table 1), however, are 
notably different from those features traditionally docu-
mented as typical of melanomas. While nearly all of our 
patients’ lesions demonstrated high internal reflectivity on 
ABC
Figure 1 Clinical imaging for Case #1. A) Fundus photo of the right eye showing 
classic optic nerve head melanocytoma. B) 10 MHz B-scan of the lesion. C) 20 MHz 
B-scan demonstrated dome shaped lesion at the optic nerve head, consistent with 
melanocytoma.
A
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Figure  2  Clinical  imaging  for  Case  #2.  A)  Fundus  photo  of  the  right  eye 
demonstrating pigmented juxtapapillary lesion which remained stable in appearance 
for several years. B) B-scan ultrasound of the lesion from (A) with apical height 
of 1.3 mm. C) Appearance of the same lesion two years later. Note invasion into 
superior optic nerve head tissue, optic disc hemorrhage, and displacement of central 
retinal vessels. D) B-scan ultrasound of the lesion from (C) showing marked increase 
in height to 3.4 mm, with associated basal dimensional growth.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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A-scan, choroidal melanomas are classically described as 
  demonstrating low internal reflectivity.11 The majority of 
the lesions in our study were observed to be avascular while 
melanomas classically are vascular.12 The highest elevation 
of any lesion in this study was 2.6 mm and the largest basal 
diameter was 4.5 mm, whereas melanomas tend to be larger 
and more elevated. Hence, ultrasound is an excellent modality 
for identifying characteristics that distinguish these lesions 
from each other.
Unfortunately, in a small percentage of cases, melano-
cytomas possess clinical and echographic features typical 
for choroidal melanomas, confusing the diagnostic process. 
A series of 115 cases of melanocytoma of the optic nerve 
head by Shields et al indicates that a significant percentage of 
optic nerve head melanocytomas grow if followed long-term 
(Kaplan-Meier estimate of 32% growth at 10 years).10 Risk 
factors for growth on univariate analysis were found to be: 
increased tumor thickness, presence of intrinsic vasculariza-
tion, and nodular (elevated) configuration. Furthermore, two 
lesions (2%) in the Shields et al series did develop malignant 
transformation during the follow-up period. We similarly 
report one such case (3%) of malignant transformation in 
our series of 30 patients. In addition to these cases, there 
are at least six other previously reported cases in which a 
previously diagnosed melanocytoma underwent malignant 
transformation to a melanoma.13–17
All three of the aforementioned risk factors can be best 
identified and followed with precision by the use of ophthal-
mic ultrasound as demonstrated in this series. Through the 
use of ultrasound, we now stratify melanocytomas into low 
or high-risk for growth and potential (albeit rare) malignant 
transformation based on the presence of 1–3 of these fea-
tures. Based on this risk designation, the necessary follow-up 
schedule for these patients can be determined. A patient with 
a tiny, flat, nonvascularized lesion need not be examined 
more than once every 1–2 years, whereas a patient with a 
large, elevated, dome-shaped, vascularized lesion, regardless 
of its funduscopic appearance, should be examined more 
frequently. Tumor margins of lesions that appear to demon-
strate interval growth can be measured with the most accurate 
precision using the high-resolution 20 MHz B-scan when 
compared to the 10 MHz B-scan, in conjunction with the 
A-scan. Our clinical experience demonstrates that using this 
combination of technologies enables us to determine internal 
reflectivity characteristics and vascularity when lesions have 
reached an apical height of just 1–2 mm. These technologies 
will allow for earlier detection of small increases in tumor 
height even in relatively small lesions, which may indicate 
rare cases of malignant transformation.
In summary, we present the echographic features of 
30 cases of optic disc melanocytomas. In this study, we 
demonstrate a new and important role for the use of 20 MHz 
high resolution ultrasound B-scan in identifying and 
  following patients with this disease presenting with high-risk 
  characteristics for growth. These tumor characteristics can 
be accurately detected with 10 MHz ultrasound and most 
reliably followed with the 20 MHz technology, in conjunc-
tion with the A-scan. Use of these modalities can aid in 
distinguishing the melanocytomas that grow from choroidal 
melanomas and in avoiding unnecessary treatments.
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